Periodontal diseases include pathological conditions elicited by the presence of bacterial
biofilms leading to a host response. In the diagnostic process, clinical signs such as …

A wide spectrum of drugs can sometimes give rise to numerous adverse orofacial
manifestations, particularly dry mouth, taste disturbances, oral mucosal ulceration, and/or …

The article identifies the molecular and cell biology of healthy and diseased periodontal
tissues. The author provides components that influence the cellular activities of adjacent …

There is an increasing number of medications associated with gingival overgrowth. These
medications are used to treat a number of common conditions in the Australian population …

Drug-induced gingival overgrowth or enlargement manifests as abnormal growth of the
gingiva due to an adverse drug reaction (ADR) in patients treated with anticonvulsants …

Drug-induced gingival overgrowth (DIGO) is a pathological growth of gingival tissue,
primarily associated with calcium channel blockers and immunosuppressants …

Gingival overgrowth (GO) is a side effect associated with some distinct classes of drugs,
such as anticonvulsants, immunosuppressant, and calcium channel blockers. GO is …

Awide spectrum of drugs can give rise to a number of adverse oral manifestations,
particularly oral mucosal ulceration and/or swelling and dry mouth. The ulceration is typically …

The predominant form of periodontal disease in children and adolescents is gingivitis, which
is a nonspecific inflammatory reaction of the marginal gingiva. The inflammatory reaction in …

Oral Diseases (2010) 16, 769–773 Objective: The aim of this work was to determine the
frequency and nature of oral manifestations secondary to use of cardiovascular drugs …